Nuria Navarro-Coy

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · The Lancet · 2010 · 566 citations · Full text

Hematological Malignancy, Zoledronic Acid, Oncology +8

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

Laura C. Coates, Anna R. Moverley, Lucy McParland et al. · The Lancet · 2015 · 466 citations · Full text

Inflammation, Rheumatology, Uk Multicentre +15

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

Andy C. Rawstron, J. A. Child, Ruth M. de Tute et al. · Journal of Clinical Oncology · 2013 · 406 citations

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

Gareth J. Morgan, J. Anthony Child, Walter M. Gregory et al. · The Lancet Oncology · 2011 · 161 citations · Full text

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis

Laura C. Coates, Nuria Navarro-Coy, Sarah R Brown et al. · BMC Musculoskeletal Disorders · 2013 · 102 citations · Full text